A down-regulation of mitochondrial biogenesis markers, including Nrf2, PPARα, and PGC-1α expression, has been reported in the animal models of doxorubicin-induced cardiotoxicity and some other cardiovascular disorders [13,33]. This evidence concerns the gene PPARGC1A and cardiovascular disorder.